Cargando…
Quantitative Mass Spectrometry-Based Proteomic Profiling for Precision Medicine in Prostate Cancer
Prostate cancer (PCa) is one of the most frequently diagnosed cancer among men in the western societies. Many PCa patients bear tumors that will not threat their lives if left untreated or if treatment is delayed. Our inability for early identification of these patients has resulted in massive overt...
Autores principales: | Flores-Morales, Amilcar, Iglesias-Gato, Diego |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674010/ https://www.ncbi.nlm.nih.gov/pubmed/29164064 http://dx.doi.org/10.3389/fonc.2017.00267 |
Ejemplares similares
-
Application of Advanced Mass Spectrometry-Based Proteomics to Study Hypoxia Driven Cancer Progression
por: Vinaiphat, Arada, et al.
Publicado: (2021) -
Mass Spectrometry-Based Label-Free Quantitative Proteomics
por: Zhu, Wenhong, et al.
Publicado: (2010) -
Quantitative SWATH-Based Proteomic Profiling for Identification of Mechanism-Driven Diagnostic Biomarkers Conferring in the Progression of Metastatic Prostate Cancer
por: Singh, Anshika N., et al.
Publicado: (2020) -
Impact of Phosphoproteomics in the Era of Precision Medicine for Prostate Cancer
por: Ramroop, Johnny R., et al.
Publicado: (2018) -
A New Era of Prostate Cancer Precision Medicine
por: Malik, Adil, et al.
Publicado: (2019)